Search - tctmd.com

Displaying 401 - 420 of 988

Sort: Relevancy | Date

Presentation TCT 2013

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

Presenter: Joshua Loh

October 29, 2013

Presentation TCT 2013

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

Presenter: Keith Oldroyd

October 29, 2013

Presentation TCT 2013

TCT-5. Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study

Presenter: Thomas Stuckey

October 29, 2013

Presentation TCT 2013

TCT-4. Efficacy and Safety of Concurrent Administration of Clopidogrel-loading (600mg) and Prasugrel-loading (60mg) in Patients with Acute ST-Segment Elevation Myocardial...

Presenter: Lorenz Raber

October 29, 2013

Presentation TCT 2013

TCT-2. Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from th...

Presenter: Tracy Wang

October 29, 2013

Presentation TCT 2013

TCT-1. Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES

Presenter: Michael Rinaldi

October 29, 2013

Presentation TCT 2013

Correlates of High Platelet Reactivity on Clopidogrel in 8,533 Patients: An ADAPT-DES Substudy

Presenter: Benjamin Vaccaro

October 29, 2013

News Conference News TCT 2013

Intraprocedural ST Predicts Adverse Short-Term Events

October 29, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

Presentation

Duration of Dual Antiplatelet Treatment with Clopidogrel and Aspirin in Patients with ACS

Presenter: Christoph Varenhorst

October 18, 2013

News Daily News

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

October 16, 2013

News Daily News

Un Estudio de Consenso Detalla el Nexo entre la Reactividad Plaquetaria y la Isquemia y las Hemorrgias

L.A. McKeown

October 15, 2013

News Daily News

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

L.A. McKeown

October 15, 2013

News Daily News

Un Pequeño Estudio Sugiere que la Protección con Filtro es Más Eficaz que la Inversión del Flujo en la Implantación de Stents Carotídeos

L.A. McKeown

October 11, 2013

News Daily News

Un Estudio Desafía las Directrices sobre Retrasos en Cirugías No Cardíacas tras PCI

L.A. McKeown

October 11, 2013

News Daily News

Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI

L.A. McKeown

October 11, 2013

News Daily News

Small Study Suggests Filter Protection More Effective Than Flow Reversal in Carotid Stenting

L.A. McKeown

October 11, 2013

Advertisement

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

TCT-5. Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study

TCT-4. Efficacy and Safety of Concurrent Administration of Clopidogrel-loading (600mg) and Prasugrel-loading (60mg) in Patients with Acute ST-Segment Elevation Myocardial...

TCT-2. Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from th...

TCT-1. Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES

Correlates of High Platelet Reactivity on Clopidogrel in 8,533 Patients: An ADAPT-DES Substudy

Intraprocedural ST Predicts Adverse Short-Term Events

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Experts Discuss Efficacy, Safety of Watchman Device

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Duration of Dual Antiplatelet Treatment with Clopidogrel and Aspirin in Patients with ACS

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

Un Estudio de Consenso Detalla el Nexo entre la Reactividad Plaquetaria y la Isquemia y las Hemorrgias

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

Un Pequeño Estudio Sugiere que la Protección con Filtro es Más Eficaz que la Inversión del Flujo en la Implantación de Stents Carotídeos

Un Estudio Desafía las Directrices sobre Retrasos en Cirugías No Cardíacas tras PCI

Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI

Small Study Suggests Filter Protection More Effective Than Flow Reversal in Carotid Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content